TrialInflammopharmacology2024
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients.
Mahmoud E Kamal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
TrialInflammopharmacology2024
Mahmoud E Kamal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.